Skip to main content

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

CLGN holding history

CollPlant Biotechnologies Ltd in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLGN overviewAll 13F holders of CLGNFull Q2 2026 holdings

Shares (Q2 2026)
71
Value
$25
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CLGN by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202671$25<0.1%00.0%UnchangedHolders
Q1 202671$38<0.1%−3,182−97.8%ReducedHolders
Q4 20253,253$4.55K<0.1%00.0%UnchangedHolders
Q3 20253,253$8.75K<0.1%−10.0%ReducedHolders
Q2 20253,254$4.42K<0.1%00.0%UnchangedHolders
Q1 20253,254$8.39K<0.1%+10.0%AddedHolders
Q4 20243,253$11.7K<0.1%00.0%UnchangedHolders
Q3 20243,253$16.2K<0.1%−10.0%ReducedHolders
Q2 20243,254$16.2K<0.1%−824−20.2%ReducedHolders
Q1 20244,078$21.8K<0.1%+4,007+5,643.7%AddedHolders
Q4 202371$454<0.1%−8,485−99.2%ReducedHolders
Q3 20238,556$47.7K<0.1%−1,058−11.0%ReducedHolders
Q2 20239,614$78.5K<0.1%00.0%UnchangedHolders
Q1 20239,614$67.5K<0.1%−3,025−23.9%ReducedHolders
Q4 202212,639$105.5K<0.1%−3,743−22.8%ReducedHolders
Q3 202216,382$111.0K<0.1%00.0%UnchangedHolders
Q2 202216,382$131.0K<0.1%00.0%UnchangedHolders
Q1 202216,382$192.0K<0.1%−3,684−18.4%ReducedHolders
Q4 202120,066$328.0K<0.1%−1,228−5.8%ReducedHolders
Q3 202121,294$360.0K<0.1%+16,995+395.3%AddedHolders
Q2 20214,299$91.0K<0.1%−823−16.1%ReducedHolders
Q1 20215,122$69.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.